Therefore, specific populations of NKR+ lymphocytes in the circulation of RA patients is associated with response to therapy and remission, and may be linked to disease flare following withdrawal of TNFi, prior to clinical symptoms of disease. The gene discussed is KLRB1; the disease is rheumatoid arthritis.